Trump Says He’s Taking Hydroxychloroquine Preventatively

SMG/Zuma

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

For weeks, President Trump has been touting the anti-malarial medication hydroxychloroquine as a “miracle drug” for treating COVID-19. On Monday, he admitted that he has been taking it prophylactically for a week and a half.

“A lot of good things have come out about the hydroxy,” he said. “I happen to be taking it. I happen to be taking it.” 

Trump slipped the revelation in at the end of a “roundtable with restaurant executives and industry leaders” in which he railed against the whistleblower who revealed the Trump–Ukraine scandal and defended Secretary of State Mike Pompeo’s alleged habit of having a staffer perform household tasks. (Trump’s justification? “Maybe his wife isn’t there.”) But of all the absurd things Trump said, his purported use of a non-approved drug for an illness he doesn’t have takes the cake.

When asked for evidence of the drug’s efficacy, Trump replied, “Here’s my evidence: I get a lot of positive calls about it.” 

The drug, which is used to treat lupus and arthritis, has not been proven to be effective in treating COVID-19, though a clinical trial is underway. In an observational study of hospitalized COVID-19 patients published in the New England Journal of Medicine, researchers found that “hydroxychloroquine administration was not associated with either a greatly lowered or an increased risk of the composite end point of intubation or death” and noted that randomized, controlled trials are still needed. The Food and Drug Administration has warned against its use outside of hospital settings.

Watch the video below:

WE'LL BE BLUNT:

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't find elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

WE'LL BE BLUNT

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate